$Oracle(ORCL)$ ORCL's market cap has fallen to just $395B. FY2027 projected EPS is $8.14–$8.31, and FY2028 projected EPS is $11.02. That works out to roughly 16x FY2027 earnings and only 12x FY2028 earnings. Somehow, one of the biggest players in the AI infrastructure buildout is being priced like a declining legacy name. Wall Street loves AI, until it comes time to value Oracle. Hard to find the words here.
$Oracle(ORCL)$ Down 9% with no volume spike to back it up. Market makers can push the price around and mess with sentiment pretty easily, but fundamentally nothing has changed.
$Oracle(ORCL)$ Larry Ellison canceled his sell orders and is holding all his shares, and then another Oracle insider made a $3.5 million purchase. Hard to be bearish after that.
$Oracle(ORCL)$ Insiders are buying, and Larry Ellison refused to sell his shares at 150, canceling a scheduled sale even though he needed money to help out his son. I'm not going to sell. This is the AI era. Price targets range from 200 to 400. If you sell, that's on you.
$Oracle(ORCL)$ CNBC reported that OpenAI saw 77% total run rate growth in its third quarter, along with 107% run rate growth for its enterprise business during the same period. I think we could get back above 140.
$Oracle(ORCL)$ The OpenAI revenue news is not a nothing burger. It is one of the most bullish things I have seen. This company basically had no revenue four years ago and now does $50B. We have never seen anything like this with them and Anthropic. They are bigger than almost every company in the world. Dumbest selloff I have ever seen.
$Oracle(ORCL)$ If you bought ORCL in 2023–2024 and just held it, you've basically made nothing over the past 2–3 years. The stock is trading back around pre-AI levels, as if the AI boom never happened and that massive $680B backlog simply doesn't exist. The market is pricing in almost none of the future value. At this point, it may take until 2030 to finally see $400+. The thesis hasn't disappeared. The waiting is just painful as hell.
$Oracle(ORCL)$ Green at the close feels nice for once. My view on this stock is that it could reach $170-180 by end of October. December looks decent too, hoping for a stable $190+ level, and $210+ would be great, driven by earnings.